Due Diligence → Portfolio Standards → Regulatory Risk → Commercialization → Innovator Bias → Data Oversight. One clinical lens, applied at every stage of the deal.
A short conversation to understand the deal, the portfolio, or the product and whether there's a clinical risk worth a closer look.
We define the right level of support based on your needs, whether it’s a one-time project, ongoing advisory support, or an embedded clinical leadership role.
Clinical review of the product, protocols, team, and documentation surfacing what needs attention before anyone else finds it.
Regular check-ins, portfolio reviews, and hands-on support as the company or portfolio scales.
Standing clinical oversight across your active pipeline and portfolio ad hoc deal reviews as they come up, monthly portfolio check-ins, and a direct line for clinical questions between meetings.